Do non-genomically encoded fusion transcripts cause recurrent chromosomal translocations?

Cancers

Volumn 4, Issue 4, 2012, Pages 1036-1049

  Kowarz, Eric ^a   Dingermann, Theo ^a   Marschalek, Rolf ^a  

^a GOETHE UNIVERSITY   (Germany)

Author keywords

Genetic rearrangements; Leukemia; Premature transcript termination; Recurrent chromosomal translocations; RNA templated DNA repair; Solid tumors

Indexed keywords

MESSENGER RNA; MIXED LINEAGE LEUKEMIA PROTEIN; NUCLEOPORIN 98; TRANSCRIPTION FACTOR ETV6; TRANSCRIPTION FACTOR RUNX1;

3' UNTRANSLATED REGION; AF4 GENE; AF9 GENE; ARTICLE; CHROMOSOME TRANSLOCATION; ELL GENE; ENL GENE; ETV6 GENE; EWSR1 GENE; GENE CLUSTER; GENE FREQUENCY; GENE FUSION; GENE LOCATION; GENE REARRANGEMENT; GENETIC ASSOCIATION; GENETIC RECOMBINATION; GENETIC SELECTION; HEMATOLOGIC MALIGNANCY; HUMAN; HUMAN CELL; MLL GENE; NUP98 GENE; ONCOGENE; RNA SPLICING; RUNX1 GENE;

EID: 84871556819     PISSN: None     EISSN: 20726694     Source Type: Journal    
DOI: 10.3390/cancers4041036     Document Type: Article

References (33)

1. Reichel, M.; Gillert, E.; Nilson, I.; Siegler, G.; Greil, J.; Fey, G.H.; Marschalek, R. Fine structure of translocation breakpoints in leukemic blasts with chromosomal translocation t(4;11): The DNA damage-repair model of translocation. Oncogene 1998, 17, 3035-3044.
2. Marcucci, G.; Strout, M.P.; Bloomfield, C.D.; Caligiuri, M.A. Detection of unique ALL1 (MLL) fusion transcripts in normal human bone marrow and blood: Distinct origin of normal versus leukemic ALL1 fusion transcripts. Cancer Res. 1998, 58, 790-793.
3. Uckun, F.M.; Herman-Hatten, K.; Crotty, M.L.; Sensel, M.G.; Sather, H.N.; Tuel-Ahlgren, L.; Sarquis, M.B.; Bostrom, B.; Nachman, J.B.; Steinherz, P.G, et al. Clinical significance of MLL-AF4 fusion transcript expression in the absence of a cytogenetically detectable t(4;11)(q21;q23) chromosomal translocation. Blood 1998, 92, 810-821.
4. Biernaux, C.; Loos, M.; Sels, A.; Huez, G.; Stryckmans, P. Detection of major bcr-abl gene expression at a very low level in blood cells of some healthy individuals. Blood 1995, 86, 3118-3122.
5. Bose, S.; Deininger, M.; Gora-Tybor, J.; Goldman, J.M.; Melo, J.V. The presence of typical and atypical BCR-ABL fusion genes in leukocytes of normal individuals: Biologic significance and implications for the assessment of minimal residual disease. Blood 1998, 92, 3362-3367.
6. Eguchi-Ishimae, M.; Eguchi, M.; Ishii, E.; Miyazaki, S.; Ueda, K.; Kamada, N.; Mizutani, S. Breakage and fusion of the TEL (ETV6) gene in immature B lymphocytes induced by apoptogenic signals. Blood 2001, 97, 737-743.
7. Quina, A.S.; Gameiro, P.; Sá da Costa, M.; Telhada, M.; Parreira, L. PML-RARA fusion transcripts in irradiated and normal hematopoietic cells. Genes Chrom. Cancer 2000, 29, 266-275.
8. Beylot-Barry, M.; Groppi, A.; Vergier, B.; Pulford, K.; Merlio, J.P. Characterization of t(2;5) reciprocal transcripts and genomic breakpoints in CD30+ cutaneous lymphoproliferations. Blood 1998, 91, 4668-4676.
9. Maes, B.; Vanhentenrijk, V.; Wlodarska, I.; Cools, J.; Peeters, B.; Marynen, P.; de Wolf-Peeters, C. The NPM-ALK and the ATIC-ALK fusion genes can be detected in non-neoplastic cells. Am. J. Pathol. 2001, 158, 2185-2193.
10. Mori, H.; Colman, S.M.; Xiao, Z.; Ford, A.M.; Healy, L.E.; Donaldson, C.; Hows, J.M.; Navarrete, C.; Greaves, M. Chromosome translocations and covert leukemic clones are generated during normal fetal development. Proc. Natl. Acad. Sci. USA 2002, 99, 8242-8247.
11. Kowarz, E.; Merkens, J.; Karas, M.; Dingermann, T.; Marschalek, R. Premature transcript termination, trans-splicing and DNA repair: A vicious path to cancer. Am. J. Blood Res. 2011, 1, 1-12.
12. Nilson, I.; Löchner, K.; Siegler, G.; Greil, J.; Beck, J.D.; Fey, G.H.; Marschalek, R. Exon/intron structure of the human ALL-1 (MLL) gene involved in translocations to chromosomal region 11q23 and acute leukaemias. Br. J. Haematol. 1996, 93, 966-972.
13. Scharf, S.; Zech, J.; Bursen, A.; Schraets, D.; Oliver, P.L.; Kliem, S.; Pfitzner, E.; Gillert, E.; Dingermann, T.; Marschalek, R. Transcription linked to recombination: A gene-internal promoter coincides with the recombination hot spot II of the human MLL gene. Oncogene 2007, 26, 1361-1371.
14. Li, H.; Wang, J.; Mor, G.; Sklar, J. A neoplastic gene fusion mimics trans-splicing of RNAs in normal human cells. Science 2008, 321, 1357-1361.
15. Li, H.; Wang, J.; Ma, X.; Sklar, J. Gene fusions and RNA trans-splicing in normal and neoplastic human cells. Cell Cycle 2009, 8, 218-222.
16. Strissel, P.L.; Strick, R.; Tomek, R.J.; Roe, B.A.; Rowley, J.D.; Zeleznik-Le, N.J. DNA structural properties of AF9 are similar to MLL and could act as recombination hot spots resulting in MLL/AF9 translocations and leukemogenesis. Hum. Mol. Genet. 2000, 9, 1671-1679.
17. Hensel, J.P.; Gillert, E.; Fey, G.H.; Marschalek, R. Breakpoints of t(4;11) translocations in the human MLL and AF4 genes in ALL patients are preferentially clustered outside of high-affinity matrix attachment regions. J. Cell Biochem. 2001, 82, 299-309.
18. Strick, R.; Zhang, Y.; Emmanuel, N.; Strissel, P.L. Common chromatin structures at breakpoint cluster regions may lead to chromosomal translocations found in chronic and acute leukemias. Hum. Genet. 2006, 119, 479-495.
19. Strissel, P.L.; Strick, R.; Rowley, J.D.; Zeleznik-Le, N.J. An in vivo topoisomerase II cleavage site and a DNase I hypersensitive site colocalize near exon 9 in the MLL breakpoint cluster region. Blood 1998, 92, 3793-3803.
20. Aplan, P.D.; Chervinsky, D.S.; Stanulla, M.; Burhans, W.C. Site-specific DNA cleavage within the MLL breakpoint cluster region induced by topoisomerase II inhibitors. Blood 1996, 87, 2649-2658.
21. Nasr, F.; Macintyre, E.; Venuat, A.M.; Bayle, C.; Carde, P.; Ribrag, V. Translocation t(4;11)(q21;q23) and MLL gene rearrangement in acute lymphoblastic leukemia secondary to anti topoisomerase II anticancer agents. Leuk. Lymphoma 1997, 25, 399-401.
22. Megonigal, M.D.; Cheung, N.K.; Rappaport, E.F.; Nowell, P.C.; Wilson, R.B.; Jones, D.H.; Addya, K.; Leonard, D.G.; Kushner, B.H.; Williams, T.M, et al. Detection of leukemia-associated MLL-GAS7 translocation early during chemotherapy with DNA topoisomerase II inhibitors. Proc. Natl. Acad. Sci. USA 2000, 97, 2814-2819.
23. Felix, C.A. Leukemias related to treatment with DNA topoisomerase II inhibitors. Med. Pediatr. Oncol. 2001, 36, 525-535.
24. Stanulla, M.; Wang, J.; Chervinsky, D.S.; Thandla, S.; Aplan, P.D. DNA cleavage within the MLL breakpoint cluster region is a specific event which occurs as part of higher-order chromatin fragmentation during the initial stages of apoptosis. Mol. Cell Biol. 1997, 17, 4070-4079.
25. Betti, C.J.; Villalobos, M.J.; Diaz, M.O.; Vaughan, A.T. Apoptotic triggers initiate translocations within the MLL gene involving the nonhomologous end joining repair system. Cancer Res. 2001, 61, 4550-4555.
26. Stanulla, M.; Chhalliyil, P.; Wang, J.; Jani-Sait, S.N.; Aplan, P.D. Mechanisms of MLL gene rearrangement: Site-specific DNA cleavage within the breakpoint cluster region is independent of chromosomal context. Hum. Mol. Genet. 2001, 10, 2481-2491.
27. Sim, S.P.; Liu, L.F. Nucleolytic cleavage of the mixed lineage leukemia breakpoint cluster region during apoptosis. J. Biol. Chem. 2001, 276, 31590-31595.
28. Meyer, C.; Kowarz, E.; Hofmann, J.; Renneville, A.; Zuna, J.; Trka, J.; Ben Abdelali, R.; Macintyre, E.; de Braekeleer, E.; de Braekeleer, M, et al. New insights to the MLL recombinome of acute leukemias. Leukemia 2009, 23, 1490-1499.
29. Storici, F.; Bebenek, K.; Kunkel, T.A.; Gordenin, D.A.; Resnick, M.A. RNA-templated DNA repair. Nature 2007, 447, 338-341.
30. Storici, F. RNA-mediated DNA modifications and RNA-templated DNA repair. Curr. Opin. Mol. Ther. 2008, 10, 224-230.
31. ENCODE Project Consortium; Birney, E.; Stamatoyannopoulos, J.A.; Dutta, A.; Guigó, R.; Gingeras, T.R.; Margulies, E.H.; Weng, Z.; Snyder, M.; Dermitzakis, E.T. et al. Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project. Nature 2007, 447, 799-816.
32. Gingeras, T.R. Implications of chimaeric non-co-linear transcripts. Nature 2009, 461, 206-211.
33. Zaphiropoulos, P.G. Trans-splicing in higher eukaryotes: Implications for cancer development? Front. Genet. 2011, 2, 92.